Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered neural tissue implants for the treatment of spinal cord injury, today announced positive results from ...

Researchers from RCSI University of Medicine and Health Sciences have developed a novel implant that delivers tiny growth-promoting particles directly to injured nerve cells, helping them to regrow ...

Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by SERPINA1 gene mutations, leading to conditions like pulmonary emphysema and liver dysfunction. The AATD market is in its ...

Researchers develop a 3D-printed, RNA-activated implant that silences the PTEN gene to promote nerve regrowth after spinal cord injury.

Researchers created a 3D biomaterial implant that delivers RNA to injured spinal cord neurons. The approach silences PTEN, removes internal repair barriers, and significantly boosts neuron regrowth in ...